Cost-Effectiveness Analysis of Formoterol Versus Salmeterol in Patients with Asthma

Author： Rutten-van Mölken M.P.M.H.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.14, Iss.6, 1998-12, pp. : 671-684

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-Effectiveness and Cost-Utility of Beclomethasone/Formoterol versus Fluticasone Propionate/Salmeterol in Patients with Moderate to Severe Asthma

By Gerzeli Simone  

Clinical Drug Investigation, Vol. 32, Iss. 4, 2012-04 ,pp. : 253-265

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Budesonide/Formoterol for Maintenance and Reliever Therapy versus Salmeterol/Fluticasone plus Salbutamol in the Treatment of Asthma

By Johansson Gunnar  

PharmacoEconomics, Vol. 24, Iss. 7, 2006-01 ,pp. : 695-708

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Comparison of Salmeterol/Fluticasone Propionate versus Montelukast in the Treatment of Adults with Persistent Asthma

By Sheth K.  

PharmacoEconomics, Vol. 20, Iss. 13, 2002-01 ,pp. : 909-918

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Fluticasone Propionate Plus Salmeterol Versus Fluticasone Propionate Plus Montelukast in the Treatment of Persistent Asthma

By Richard D. O’Connor  

PharmacoEconomics, Vol. 22, Iss. 12, 2004-01 ,pp. : 815-825

Adis International

Access to resources Recommend Favorite

Dermatan Sulfate versus Unfractionated Heparin for the Prevention of Venous Thromboembolism in Patients Undergoing Surgery for Cancer: A Cost-Effectiveness Analysis

By Attanasio E.  

PharmacoEconomics, Vol. 19, Iss. 1, 2001-01 ,pp. : 57-68

Adis International

Access to resources Recommend Favorite